Synthesis and purification of 2-bromo-α-ergocryptine-82Br
✍ Scribed by S. P. Markey; R. W. Colburn; I. J. Kopin
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- French
- Weight
- 164 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Bromocryptine (2-brom-a-ergocryptine, I) has been found t o be a dopamine agonist used f o r treatment of endocrine disorders and more recently f o r the treatment of Parkinsonism (12'). metabolism and pharmacokinetic studies, a radiolabelled drug was desired.
Recent studies have demonstrated the u t i l i t y of 82Br labelled drugs prepared by synthesis (3) o r d i r e c t neutron irradiation (4). W e have In order t o perform chosen synthesis t o avoid decomposition anticipated from recoil labelling.
A d i l u t e solution of a-ergocryptine (11) was found to react specifically
📜 SIMILAR VOLUMES
## Abstract A high incidence of mammary tumors is found in multiparous GR mice during the 2nd and 3rd pregnancies and in nulliparous GR mice treated with estrone/progesterone. The purpose of this study was to determine if prolactin is a contributing hormone in the genesis of these neoplasms. In one
The synthesis of 2-deoxy-2-[82Br]bromo-3,4,6-tri-O-acetyl-alpha-D-mannopyranosyl chloride (compound 3b) and 2-deoxy-2-[82Br]bromo-D-mannose (compound 4b), and their biodistributions in mice are described. The reaction of 3,4,6-tri-O-acetyl-D-glucal (compound 2) with unlabeled and labeled bromine chl
Synthesis and evaluation of 82Br and 77Br labeled (17a, 20E)-21-bromo-19-norpregna-l,3,5(10),20-tetraene-3,17~ -diol